STAT5a plays a vital role in the promotion of cancers, including lung cancer (9), prostate cancer (10), and gastric cancer (11); is involved in chemoresistance in esophageal cancer by negatively regulating miR-29c (12); and is overexpressed in gemcitabine-resistant pancreatic cancer cell lines (13). The gene discussed is STAT5A; the disease is cancer.